王可可,贾强,李三鸣
WANG Ke-ke1,JIA Qiang2,LI San-ming1(1.School of Pharmacy

• 1:沈阳药科大学药学院
• 2:香港澳美制药有限公司

摘要(Abstract)：

目的介绍有机凝胶的分类及其在药学中的应用情况。方法参阅国内外代表性文献资料,以其中的53篇为依据对其进行分析、归纳和整理。结果阐明了不同种类有机凝胶的分子特点、结构类型及凝胶形成机理,并对其在经皮给药、皮下植入、口服和黏膜给药等方面的应用加以综述。结论有机凝胶在药学领域具有广阔的应用及发展前景。
Objective To summarize the species of organogels and their applications in drug delivery.Methods At least 53 representative papers recently published were consulted,analyzed and summarized.Results The molecular properties,structure types and formation mechanisms of different organogels were illustrated;their applications in transdermal,parenteral depot,oral and trans-mucosal formulations were reviewed.Conclusions The organogel systems have become widely known as a very attractive platform for drug delivery.

关键词(KeyWords)： 有机凝胶;有机凝胶因子;经皮给药;皮下贮库;口服给药;粘膜给药
organogel;organogelator;transdermal formulation;parenteral depot formulation;oral formulation;trans-mucosal formulation

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(30772670)

作者(Author): 王可可,贾强,李三鸣
WANG Ke-ke1,JIA Qiang2,LI San-ming1(1.School of Pharmacy

DOI: 10.14066/j.cnki.cn21-1349/r.2010.09.019

参考文献(References)：

• [1]黎坚,崔文瑾,王理,等.可聚合凝胶因子的合成及其有机凝胶热力学研究[J].有机化学,2002,22(9):651-657.
• [2]朱丽雯,孙培冬.脂肪酰谷氨酸与小分子有机凝胶[J].化学通报,2007,3(8):233-236.
• [3]TERECHP,WEISS R G.Low molecular mass gelatorsof organic liquids and the properties of their gels[J].Chem Rev,1997,97(8):3133-3159.
• [4]ESCH J H,FERINGA B L.New functional materialsbased on selfassembling organogels:from serendipity to-wards design[J].Angew Chem Int Ed,2000,39(13):2263-2266.
• [5]VINTILOIU A,LEROUX J C.Organogels and their usein drug delivery-A review[J].J Control Release,2008,125(3):179-192.
• [6]FUHRHOP J H,HELFRICH W.Fluid and solid fibersmade of lipid molecular bilayers[J].Chem Rev,1993,93(4):1565-1582.
• [7]SHCHIPUNOV Y A.Self-organising structures of leci-thin[J].Russ Chem Rev,1997,66(4):301-322.
• [8]FAGES F,VOGTLE F,ZINIC M.Top Curr Chem[M].Heidelberg:Springer Berlin,2005:77-131.
• [9]YOZA K,AMANOKURA N,ONO Y.Sugar-integratedgelators of organic solvents-their remarkable diversity ingelation ability and aggregate structure[J].Chem EurJ,1999,5(9):2722-2729.
• [10]LUBORADZKI R,GRONWALD O,IKADA A.Sugar-integrated“supergelators”which can form organogelswith 0.03%-0.05%[J].Chem Lett,2000,10:1148-1149.
• [11]CHOW H F,ZHANG J,LO C M.Improving the gela-tion properties of 3,5-diaminobenzoate-based organog-elators in aromatic solvents with additional aromatic-containing pendants[J].Tetrahedron,2007,63(2):363-373.
• [12]王宏,汪芳芳,唐海涛,等.亚苄基山梨醇衍生物在有机溶剂中的自组装及凝胶化研究[J].化学学报,2007,65(11):1057-1063.
• [13]ABDALLAHD J,WEISS R G.n-Alkanes geln-alkanes(and many other organic liquids)[J].Langmuir,2000,16(2):352-355.
• [14]WANG Hong,ZHANG Jin-ye,ZHANG Wei-ping,etal.Host-guest interactions of 5-fluorouracil in supramo-lecular organogels[J].Eur J Pharm Biopharm,2009,73(3):357-360.
• [15]ZINIC M,VOGTLE F,FAGES F.Top Curr Chem[M].Heidelberg:Springer Berlin,2005:39-76.
• [16]SCARTAZZINI R,LUISI P L.Organogels from leci-thins[J].J Phys Chem,1988,92(3):829-833.
• [17]SHCHIPUNOV Y A,SHUMILINA E V.Lecithin or-ganogels:role of polar solvent and nature of intermolec-ular interactions[J].Colloid J,1996,58(1):117-125.
• [18]SHCHIPUNOV Y A,SHUMILINA E V.Lecithin bridg-ing by hydrogen bonds in the organogel[J].C BiomimSupramol Syst,1995,3(1):43-50.
• [19]MURDAN S,GREGORIADIS G.,FLORENCE A T.Non-ionic surfactant based organogels incorporatingniosomes[J].STP Pharma Sci,1996,6(1):44-48.
• [20]MURDAN S,BERGH B,GREGORIADIS G.Water-in-sorbitan monostearate organogels(water-in-oil gels)[J].J Pharm Sci,1999,88(6):615-619.
• [21]MURDAN S,GREGORIADIS G,FLORENCE A T.In-teraction of a nonionic surfactantbased organogel with a-queous media[J].Int J Pharm,1999,180(2):211-214.
• [22]MURDAN S,GREGORIADIS G,FLORENCE A T.No-vel sorbitan monostearate organogels[J].J Pharm Sci,1999,88(6):608-614.
• [23]JIBRY N,HEENAN R K,MURDAN S.Amphiphilogelsfor drug delivery:formulation and characterization[J].Pharm Res,2004,21(10):1852-1861.
• [24]ROBINSON R C.Plastibase,a hydrocarbon gel oint-ment base[J].Bull Sch Med Univ Md,1955,40(3):86-89.
• [25]GOTO S,KAWATA M,SUZUKI T,et al.Preparationand evaluation of Eudragit gels.I:Eudragit organogelscontaining drugs as rectal sustainedrelease preparations[J].J Pharm Sci,1991,80(10):958-961.
• [26]KAWATA M,SUZUKI T,KIM N S,et al.Preparationand evaluation of Eudragit gels.II:In vitrorelease ofsalicylic acid,sodium salicylate,and ketoprofen fromEudragit L and S organogels[J].J Pharm Sci,1991,80(11):1072-1074.
• [27]KUMAR R,KATARE P O.Lecithin organogels as apotential phospholipid-structured system for topicaldrug delivery:a review[J].AAPS Pharm Sci Tech,2005,6(2):298-310.
• [28]WILLIMANN H,WALDE P,LUISI P L.Lecithin or-ganogel as matrix for transdermal transport of drugs[J].J Pharm Sci,1992,81(9):871-874.
• [29]BHATNAGAR S,VYAS S P.Organogel-based systemfor transdermal delivery of propranolol[J].J Microen-capsul,1994,11(4):431-438.
• [30]SHAIKHI M,JADHAV K R,GIDE P S.Topical deliv-ery of aceclofenac from lecithin organogels:preformula-tion study[J].Curr Drug Deliv,2006,3(4):417-427.
• [31]AGRAWAL G P,JUNEJA M,AGRAWAL S.Prepara-tion and characterization of reverse micelle based or-ganogels of piroxicam[J].Pharmazie,2004,59(3):191-193.
• [32]COGAN A,GARTI N.Microemulsions as transdermaldrug delivery vehicles[J].Adv Colloid Interface Sci,2006,123-126:369-385.
• [33]DREHER F,WALDE P,WALTER P.Interaction of alecithin microemulasion gel with human stratum corne-um and its effect on transdermal transport[J].J ControlRelease,1997,45(2):131-140.
• [34]BENTLEY M V L B,KEDOR E R M,VIANNA R F.The influence of lecithin and urea on thein vitroper-meation of hydrocortisone acetate through skin fromhairless mouse[J].Int J Pharm,1997,146(2):255-262.
• [35]MAHJOUR M,MAUSER B,RASHIDBAIGI Z.Effectof egg yolk lecithins and commercial soybean lecithinsonin vitropermeation of drugs[J].J Control Release,1990,14(3):243-252.
• [36]NASTRUZZI C,GAMBARI R.Antitumor activity of(trans)dermally delivered aromatic tetra-amidines[J].J Control Release,1994,29(1/2):53-62.
• [37]DREHER F,WALDE P,LUISI P L.Human skin irrita-tion studies of a lecithin microemulsion gel and of leci-thin liposomes[J].Skin Pharmacol,1996,9(2):124-129.
• [38]GRACE D,ROGERS J,SKEITH K.Topical diclofenacversus placebo:a double blind,randomized clinical trialin patients with osteoarthritis of the knee[J].J Rheu-matol,1999,26(12):2659-2663.
• [39]NOKHODCHI A,SHOKRI J,DASHBOLAGHI A.Theenhancement effect of surfactants on the penetration oflorazepam through rat skin[J].Int J Pharm,2003,250(2):359-369.
• [40]JIBRY N,MURDAN S.In vivoinvestigation,in miceand man,into the irritation potential of novel amphiphi-logels being studied as transdermal drug carriers[J].Eur J Pharm Biopharm,2004,58(1):107-119.
• [41]PPENZES T,CSOKA I,EROS I.Rheological analysisof the structural properties effecting the percutanneousabsorption and stability in pharmaceutical organogels[J].Rheol Acta,2004,43(5):457-463.
• [42]PENZES T,BLAZSO G,AIGNER Z.Topical absorptionof piroxicam from organogels-in vitroandin vivocorre-lations[J].Int J Pharm,2005,298(1):47-54.
• [43]LIM P F C,LIU X Y,KANG L F,et al.Physicochemi-cal effects of terpenes on organogel for transdermal drugdelivery[J].Int J Pharm,2008,358(1/2):102-107.
• [44]NAJJAR TA,SLEEPER HR,CALABRESI P.The useof 5-iodo-2′-deoxyuridine(IUDR)in Orabase and plas-tibase for treatment of oral herpes simplex[J].J OralMed,1969,24(2):53-57.
• [45]MURDANS,GREGORIADIS G,FLORENCE AT.Sor-bitan monostearate/polysorbate 20 organogels contai-ning niosomes:a delivery vehicle for antigens[J].Eur JPharm Sci,1999,8(3):177-186.
• [46]GAO Z H,CROWLEY W R,SHUKLA A J.Controlledrelease of contraceptive steroids from biodegradable andinjectable gel formulations-in vivoevaluation[J].PharmRes,1995,12(6):864-868.
• [47]PLOURDE F,MOTULSKY A,COUFFIN-HOARAU AC.First report on the efficacy ofL-alanine-basedin si-tu-forming implants for the long-term parenteral deliver-y of drugs[J].J Control Release,2005,108(2/3):433-441.
• [48]VINITILOIU A,LAFLEUR M,BASTIAT G.In situ-forming oleogel implant for sustained release of rivastig-mine[J].Pharm Res,2008,25(4):845-852.
• [49]贾强,王可可,韩飞,等.氟比洛芬有机原位凝胶的制备及体外释放行为的考察[J].中国药剂学杂志,2009,7(5):365-371.
• [50]MURDAN S,ANDRYSEK T,SON D.Novel gels andtheir dispersions-oral drug delivery systems for ciclos-porin[J].Int J Pharm,2005,300(1/2):113-124.
• [51]GOTO S,KAWATA M,SUZUKI T.Preparation and e-valuation of Eudragit gels.I:Eudragit organogels contai-ning drugs as rectal sustainedrelease preparations[J].JPharm Sci,1991,80(10):958-961.
• [52]CUI Z,MUMPER R J.Bilayer films for mucosal(genet-ic)immunization via the buccal route in rabbits[J].Pharm Res,2002,19(7):947-953.
• [53]PISAL S,SHELKE V,MAHADIK K.Effect of organo-gel components onin vitronasal delivery of propranololhydrochloride[J].AAPS Pharm Sci Tech,2004,5(4):e63.